ViroPharma Provides Further Update on Picovir� NDA
June 04, 2002 21:00 ET | ViroPharma Incorporated
EXTON, Pa., June 4, 2002 (PRIMEZONE) -- As the Company expected and had previously announced, ViroPharma Incorporated (Nasdaq:VPHM) recently received a "not approvable" letter from the U.S. Food and...
Meda Signs Long Term Strategic Agreement with Ranbaxy
May 22, 2002 04:45 ET | Meda
STOCKHOLM, Sweden, May 22, 2002 (PRIMEZONE) -- Meda has entered into a long-term strategic agreement with India's largest pharmaceutical company, Ranbaxy Laboratories Limited, regarding generic...
NeuroSearch's 1Q Report, 2002
May 17, 2002 07:24 ET | NeuroSearch
BALLERUP, Denmark, May 17, 2002 (PRIMEZONE) -- Telephone Conference, NeuroSearch's (Pink Sheets:NEUSF) 1Q report 2002. Tuesday the 21 of May 2002 at 3 p.m. CET (9 a.m. EST, 2 p.m. GMT) President,...
Karo Bio's Capital Markets Day in London
May 16, 2002 02:40 ET | Karo Bio
HUDDINGE, Sweden, May 16, 2002 (PRIMEZONE) -- Karo Bio, a leading international drug discovery company focusing on nuclear receptors as drug targets, will today present an overview of the Company for...
PharmChem Reports First Quarter 2002 Results
May 15, 2002 12:49 ET | PharmChem, Inc.
HALTOM CITY, Texas, May 15, 2002 (PRIMEZONE) -- PharmChem, Inc., (Nasdaq:PCHM) announced that its net sales from continuing operations for the first quarter ended March 31, 2002 were $7,476,000, or...
ViroPharma and Aventis Provide Update on Picovir� NDA
May 09, 2002 18:19 ET | ViroPharma Incorporated
EXTON, Pa. and BRIDGEWATER, N.J., May 9, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) recently met with officials from the U.S. Food and Drug Administration to discuss ViroPharma's new...
Astex and Maybridge Announce Exclusive Lead Discovery Collaboration
May 07, 2002 03:00 ET | Astex Therapeutics
CAMBRIDGE, U.K. and CORNWALL, U.K., May 7, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, and Maybridge plc, a world leader in the supply of small molecule...
Competitive Technologies Licensee Provides Update on Clinical Trials
May 01, 2002 12:05 ET | Competitive Technologies, Inc.
FAIRFIELD, Conn., May 1, 2002 (PRIMEZONE) -- Competitive Technologies, Inc. (AMEX:CTT) today reported that its licensee, Ribozyme Pharmaceuticals Inc. (Nasdaq:RZYM) provided updates on the Phase II...
ViroPharma Incorporated Reports First Quarter Financial Results
May 01, 2002 08:00 ET | ViroPharma Incorporated
EXTON, Pa., May 1, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today reported financial results for the first quarter ended March 31, 2002. For the quarter ended March 31, 2002,...
Karo Bio's Annual General Meeting
April 26, 2002 03:21 ET | Karo Bio
HUDDINGE, Sweden, April 26, 2002 (PRIMEZONE) -- Karo Bio: At Karo Bio AB's Annual General Meeting on April 25, 2002 the following was resolved. Dividend No dividend is to be paid for the...